Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases. According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases. Market Analysis and Insights: Global Enteric Disease Testing and Therapeutic Market The global Enteric Disease Testing and Therapeutic market size is projected to reach US$ 3330.2 million by 2027, from US$ 3014.3 million in 2020, at a CAGR of 1.4% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enteric Disease Testing and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enteric Disease Testing and Therapeutic market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enteric Disease Testing and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enteric Disease Testing and Therapeutic market. Global Enteric Disease Testing and Therapeutic Scope and Market Size Enteric Disease Testing and Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enteric Disease Testing and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Bacterial Disease Viral Disease Parasitic Disease Segment by Application Hospital Specialty Clinic Others By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Abbott GlaxoSmithKline Becton Dickinson bioMérieux Sanofi Bayer Pharma Bio-Rad Quest Diagnostics Trinity Biotech
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Bacterial Disease 1.2.3 Viral Disease 1.2.4 Parasitic Disease 1.3 Market by Application 1.3.1 Global Enteric Disease Testing and Therapeutic Market Share by Application: 201
